China looks for GMP gaps as it prepares to apply for PIC/S membership
This article was originally published in SRA
The China Food and Drug Administration is pressing on with efforts to join the international pharmaceutical inspection convention and co-operation scheme (PIC/S) and has launched a feasibility study to this end.
You may also be interested in...
Following the announcement in the US that ranitidine drugs must be withdrawn from the market, the European Medicines Agency told the Pink Sheet it would decide on the fate of these medicines in the EU after wrapping up its own inquiry.
EU drug industry federation, EFPIA, is concerned that an increase in protectionist trade measures by some countries could result in tit-for-tat policies that could hamper the global response to contain COVID-19.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Sixty-nine guidance documents have been posted on the tracker since its last update.